Systemic administration of l-kynurenine sulfate induces cerebral hypoperfusion transients in adult C57Bl/6 mice
- PMID: 28546077
- DOI: 10.1016/j.mvr.2017.05.006
Systemic administration of l-kynurenine sulfate induces cerebral hypoperfusion transients in adult C57Bl/6 mice
Abstract
The kynurenine pathway is a cascade of enzymatic steps generating biologically active compounds. l-kynurenine (l-KYN) is a central metabolite of tryptophan degradation. In the mammalian brain, l-KYN is partly converted to kynurenic acid (KYNA), which exerts multiple effects on neurotransmission. Recently, l-KYN or one of its derivatives were attributed a direct role in the regulation of the systemic circulation. l-KYN dilates arterial blood vessels during sepsis in rats, while it increases cerebral blood flow (CBF) in awake rabbits. Therefore, we hypothesized that acute elevation of systemic l-KYN concentration may exert potential effects on mean arterial blood pressure (MABP) and on resting CBF in the mouse brain. C57Bl/6 male mice were anesthetized with isoflurane, and MABP was monitored in the femoral artery, while CBF was assessed through the intact parietal bone with the aid of laser speckle contrast imaging. l-KYN sulfate (l-KYNs) (300mg/kg, i.p.) or vehicle was administered intraperitoneally. Subsequently, MABP and CBF were continuously monitored for 2.5h. In the control group, MABP and CBF were stable (69±4mmHg and 100±5%, respectively) throughout the entire data acquisition period. In the l-KYNs-treated group, MABP was similar to that, of control group (73±6mmHg), while hypoperfusion transients of 22±6%, lasting 7±3min occurred in the cerebral cortex over the first 60-120min following drug administration. In conclusion, the systemic high-dose of l-KYNs treatment destabilizes resting CBF by inducing a number of transient hypoperfusion events. This observation indicates the careful consideration of the dose of l-KYN administration by interpreting the effect of kynurenergic manipulation on brain function. By planning clinical trials basing on kynurenergic manipulation possible vascular side effects should also be considered.
Keywords: C56Bl/6 mice; Cerebral blood flow; Hypoperfusion; Laser speckle flowmetry; Mean arterial blood pressure; l-Kynurenine.
Copyright © 2017 Elsevier Inc. All rights reserved.
Similar articles
-
Effect of systemic kynurenine on cortical spreading depression and its modulation by sex hormones in rat.Exp Neurol. 2012 Aug;236(2):207-14. doi: 10.1016/j.expneurol.2012.05.002. Epub 2012 May 14. Exp Neurol. 2012. PMID: 22587906
-
Transient Hypoperfusion to Ischemic/Anoxic Spreading Depolarization is Related to Autoregulatory Failure in the Rat Cerebral Cortex.Neurocrit Care. 2022 Jun;37(Suppl 1):112-122. doi: 10.1007/s12028-021-01393-z. Epub 2021 Dec 2. Neurocrit Care. 2022. PMID: 34855119 Free PMC article.
-
Systemic L-Kynurenine sulfate administration disrupts object recognition memory, alters open field behavior and decreases c-Fos immunopositivity in C57Bl/6 mice.Front Behav Neurosci. 2015 Jun 16;9:157. doi: 10.3389/fnbeh.2015.00157. eCollection 2015. Front Behav Neurosci. 2015. PMID: 26136670 Free PMC article.
-
Post-ischemic treatment with L-kynurenine sulfate exacerbates neuronal damage after transient middle cerebral artery occlusion.Neuroscience. 2013 Sep 5;247:95-101. doi: 10.1016/j.neuroscience.2013.04.063. Epub 2013 May 16. Neuroscience. 2013. PMID: 23685169
-
Progress in the development of kynurenine and quinoline-3-carboxamide-derived drugs.Expert Opin Investig Drugs. 2020 Nov;29(11):1223-1247. doi: 10.1080/13543784.2020.1813716. Epub 2020 Sep 2. Expert Opin Investig Drugs. 2020. PMID: 32819186 Review.
Cited by
-
Lactobacillus maintains healthy gut mucosa by producing L-Ornithine.Commun Biol. 2019 May 8;2:171. doi: 10.1038/s42003-019-0424-4. eCollection 2019. Commun Biol. 2019. PMID: 31098404 Free PMC article.
-
Tryptophan challenge in individuals with schizophrenia and healthy controls: acute effects on circulating kynurenine and kynurenic acid, cognition and cerebral blood flow.Neuropsychopharmacology. 2023 Oct;48(11):1594-1601. doi: 10.1038/s41386-023-01587-3. Epub 2023 Apr 28. Neuropsychopharmacology. 2023. PMID: 37118058 Free PMC article. Clinical Trial.
-
Commentary: The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat.Front Neurol. 2017 Sep 29;8:518. doi: 10.3389/fneur.2017.00518. eCollection 2017. Front Neurol. 2017. PMID: 29033891 Free PMC article. No abstract available.
-
A Potential Interface between the Kynurenine Pathway and Autonomic Imbalance in Schizophrenia.Int J Mol Sci. 2021 Sep 16;22(18):10016. doi: 10.3390/ijms221810016. Int J Mol Sci. 2021. PMID: 34576179 Free PMC article. Review.
-
Phase 1 study to access safety, tolerability, pharmacokinetics, and pharmacodynamics of kynurenine in healthy volunteers.Pharmacol Res Perspect. 2021 Apr;9(2):e00741. doi: 10.1002/prp2.741. Pharmacol Res Perspect. 2021. PMID: 33682377 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources